Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic

Northwest Biotherapeutics, Inc. (NWBio) announced it is establishing its own dedicated clinic, but provides no further details.

Risk flags

• ●The announcement is forward-looking, with no evidence of execution or progress.

Announcement summary

Northwest Biotherapeutics, Inc. (OTCQB:NWBO) announced that it is establishing its own dedicated clinic. The company is developing DCVax® personalized immune therapies for solid tumor cancers. The announcement was made from BETHESDA, Md. The company is also referred to as NWBio. No financial figures or timelines are provided in the text.

Disagree with this article?